Trials / Completed
CompletedNCT00562094
Efficacy of Pantoprazole in Patients Older Than 12 Years With Reflux Associated Sleep Disorders (PULS)
Pantoprazole for the Treatment of GERD Associated Symptoms Focusing on Sleep Disorders.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,616 (actual)
- Sponsor
- Nycomed · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study was to evaluate the effect of Pantoprazole 20 mg/40 mg for 14 days on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) with special focus on the reduction of symptomatic sleep disorders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pantoprazole | This was an observational study. Therefore, the physician decided about dosage according to individual needs. |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-04-01
- Completion
- 2009-04-01
- First posted
- 2007-11-21
- Last updated
- 2012-05-08
- Results posted
- 2010-09-24
Locations
1,153 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00562094. Inclusion in this directory is not an endorsement.